Related Experiment Video
Updated: Oct 1, 2026

Adult and Pediatric Porcine Model of Acute Volume Overload
Published on: January 12, 2024
Children are not small adults: some differences between pediatric and adult cardiac transplantation
1Pediatric Heart Failure and Heart Transplant Services, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk M41, Cleveland, OH 44195, USA. kichukm@ccf.org
Insights
Pediatric cardiac transplantation offers excellent survival rates for children with end-stage heart disease. Key considerations include unique indications, specialized evaluations, and comprehensive post-transplant psychosocial support for young recipients and their families.
Area of Science:
- Cardiology
- Pediatric Surgery
- Transplantation Medicine
Background:
- Cardiac transplantation is a critical treatment for end-stage heart disease in adults and children.
- Pediatric heart transplant survival rates are comparable to adult recipients, exceeding 65% at 5 years.
- Significant distinctions exist in pediatric cardiac transplantation concerning indications, patient evaluation, surgical approaches, and long-term management.
Purpose of the Study:
- To highlight the viability and outcomes of cardiac transplantation in pediatric patients.
- To outline the specific indications for heart transplantation in children.
- To emphasize the unique challenges and considerations in pediatric cardiac transplant management.
Main Methods:
- Review of indications for pediatric cardiac transplantation, including metabolic, genetic cardiomyopathies, and congenital heart disease.
- Emphasis on specialized evaluation protocols for pediatric candidates, including metabolic and genetic assessments.
- Discussion of post-transplant management focusing on pediatric-specific psychosocial needs.
Main Results:
- Pediatric cardiac transplantation demonstrates excellent survival rates, comparable to adults.
- Indications in children often involve complex conditions like metabolic disorders and congenital heart defects.
- Pre-existing palliative surgeries in children with congenital heart disease can elevate surgical risks.
Conclusions:
- Cardiac transplantation is a successful therapy for pediatric end-stage heart disease.
- Tailored evaluation and management strategies are essential for pediatric heart transplant success.
- Addressing psychosocial aspects is crucial for the holistic well-being of pediatric transplant recipients and their families.
Abstract:
Cardiac transplantation is a viable therapy for end-stage heart disease in both adults and children. Overall posttransplant survival in the pediatric age group (birth up to 18 years of age) is excellent (greater than 65% at 5 years for all age groups), comparable with the overall survival in the adult transplant recipients. Important differences exist regarding indications, evaluation, surgical technique, and posttransplant management. Indications for transplant in pediatric patients include metabolic and genetic forms of cardiomyopathy and structural congenital heart disease. Evaluation should include a metabolic workup, because potential etiologic factors include mitochondrial disorders, and genetic studies if indicated by phenotypic appearance or family pedigree. Children referred for transplantation with congenital heart disease have often had multiple attempts at palliative surgery, which increase peritransplant surgical risks. Key pediatric issues after transplantation include psychosocial support for the patient and family with regard to school, growth, development, and future expectations.
Related Concept Videos
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Kidney Transplant I: Introduction
Pharmacokinetics in Pediatric Patients: Drug Excretion

